Omeros (OMER) Inventory Average (2015 - 2026)
Omeros (OMER) posted Inventory Average of $845000.0 for Q3 2021, down 22.08% sequentially from $1.1 million in Q2 2021, and down 50.79% YoY from $1.7 million in Q3 2020.
Analysis
Omeros (OMER) Inventory Average (2015 - 2026) Analysis & Trends
Omeros has reported Inventory Average for 7 years, with the latest figure at $845000.0 in Q3 2021.
- Quarterly Inventory Average fell 50.79% year-over-year to $845000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $845000.0 (down 50.79% YoY) and the FY2020 annual result came in at $1.3 million, up 102.59% from the prior year.
- Inventory Average retreated to $845000.0 in Q3 2021 per OMER's latest filing, from $1.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $1.7 million in Q3 2020 and troughed at $151000.0 in Q4 2018.
- A 5-year average of $907684.2 and a median of $961500.0 in 2019 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2018 and 2019: Inventory Average plunged 76.13% in 2018, then jumped 668.21% in 2019.
- Over 5 years, Inventory Average stood at $632500.0 in 2017, then slumped by 76.13% to $151000.0 in 2018, then surged by 668.21% to $1.2 million in 2019, then gained by 24.87% to $1.4 million in 2020, then tumbled by 41.66% to $845000.0 in 2021.
- According to Business Quant data, Inventory Average over the past three periods registered $845000.0, $1.1 million, and $1.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 512,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 512,500.00 |
| Sep 30, 2021 | 845,000.00 |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 1.45 Mn |
| Sep 30, 2020 | 1.72 Mn |
| Jun 30, 2020 | 1.55 Mn |
| Mar 31, 2020 | 1.18 Mn |
| Dec 31, 2019 | 1.16 Mn |
| Sep 30, 2019 | 1.18 Mn |
| Jun 30, 2019 | 961,500.00 |
| Mar 31, 2019 | 412,000.00 |
| Dec 31, 2018 | 151,000.00 |
| Sep 30, 2018 | 224,500.00 |
| Jun 30, 2018 | 241,000.00 |
| Mar 31, 2018 | 345,000.00 |
| Dec 31, 2017 | 632,500.00 |
| Sep 30, 2017 | 863,500.00 |
| Jun 30, 2017 | 932,500.00 |
| Mar 31, 2017 | 1.04 Mn |